|
Market Cap (5-Jul) $206,755,376 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (19-Jun) 40,298 (0.02%) (504th) |
|
52w High $1.97 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 16 November 2020, 18:50. The announcement is not marked as price sensitive, and is 1 page(s) in length and 101.02kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.001% short sold according to ASIC data. It was ranked the 559th most shorted stock on the ASX. It is now ranked as the 504th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Cleansing Notice | 16 November 2020, 18:50 |
| Appendix 2A-Exercise of Options | 16 November 2020, 18:49 |
| Bisantrene data published in European Journal of Haematology | 10 November 2020, 12:27 |
| Phase II Bisantrene trial data to be presented at ASH 2020 | 5 November 2020, 13:20 |
You must be logged in to post a reply.
Race Oncology 